BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Wu W, Zhu X, Ng W, Gong C, Yao C, Ni Z, Yan X, Fang C, Zhu S. The Ancient Chinese Decoction Yu-Ping-Feng Suppresses Orthotopic Lewis Lung Cancer Tumor Growth Through Increasing M1 Macrophage Polarization and CD4+ T Cell Cytotoxicity. Front Pharmacol 2019;10:1333. [PMID: 31780946 DOI: 10.3389/fphar.2019.01333] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Feiyue Z, Gaofeng L. Traditional Chinese medicine and lung cancer--From theory to practice. Biomed Pharmacother 2021;137:111381. [PMID: 33601147 DOI: 10.1016/j.biopha.2021.111381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yang Y, Li N, Wang TM, Di L. Natural Products with Activity against Lung Cancer: A Review Focusing on the Tumor Microenvironment. Int J Mol Sci 2021;22:10827. [PMID: 34639167 DOI: 10.3390/ijms221910827] [Reference Citation Analysis]
3 Liu Z, Sun Q, Liu X, Song Z, Song F, Lu C, Zhang Y, Song X, Yang Y, Li Y. Network pharmacology analysis and experimental verification reveal the mechanism of the traditional Chinese medicine YU-Pingfeng San alleviating allergic rhinitis inflammatory responses. Front Plant Sci 2022;13:934130. [DOI: 10.3389/fpls.2022.934130] [Reference Citation Analysis]
4 Li W, Li Q, Guo L, Liu J, Wang K, Zhong W. Traditional Chinese Medicine Extract Properties Incorporated Energy Analysis for Membrane Concentration Processes. Membranes (Basel) 2021;11:673. [PMID: 34564490 DOI: 10.3390/membranes11090673] [Reference Citation Analysis]
5 Chen F, Li J, Wang H, Ba Q. Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment. Front Oncol 2021;11:746917. [PMID: 34722304 DOI: 10.3389/fonc.2021.746917] [Reference Citation Analysis]
6 Tang M, Li Y, Luo X, Xiao J, Wang J, Zeng X, Hu Q, Chen X, Tan SJ, Hu J. Identification of Biomarkers Related to CD8+ T Cell Infiltration With Gene Co-expression Network in Lung Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:606106. [PMID: 33816462 DOI: 10.3389/fcell.2021.606106] [Reference Citation Analysis]
7 Xu ZH, Zhu YZ, Su L, Tang XY, Yao C, Jiao XN, Hou YF, Chen X, Wei LY, Wang WT, Wang J, Gong CY, Zhu XD, Zhang F, Zhu SG, Zou CP. Ze-Qi-Tang Formula Induces Granulocytic Myeloid-Derived Suppressor Cell Apoptosis via STAT3/S100A9/Bcl-2/Caspase-3 Signaling to Prolong the Survival of Mice with Orthotopic Lung Cancer. Mediators Inflamm 2021;2021:8856326. [PMID: 33867859 DOI: 10.1155/2021/8856326] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Liu J, Wang Y, Qiu Z, Lv G, Huang X, Lin H, Lin Z, Qu P. Impact of TCM on Tumor-Infiltrating Myeloid Precursors in the Tumor Microenvironment. Front Cell Dev Biol 2021;9:635122. [PMID: 33748122 DOI: 10.3389/fcell.2021.635122] [Reference Citation Analysis]
9 Yao C, Su L, Zhang F, Zhu X, Zhu Y, Wei L, Jiao X, Hou Y, Chen X, Wang W, Wang J, Zhu X, Zou C, Zhu S, Xu Z. Thevebioside, the active ingredient of traditional Chinese medicine, promotes ubiquitin-mediated SRC-3 degradation to induce NSCLC cells apoptosis. Cancer Lett 2020;493:167-77. [PMID: 32829007 DOI: 10.1016/j.canlet.2020.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Chen Y, Jin H, Song Y, Huang T, Cao J, Tang Q, Zou Z. Targeting tumor-associated macrophages: A potential treatment for solid tumors. J Cell Physiol 2021;236:3445-65. [PMID: 33200401 DOI: 10.1002/jcp.30139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Lv YX, Pan HR, Song XY, Chang QQ, Zhang DD. Hedyotis diffusa plus Scutellaria barbata Suppress the Growth of Non-Small-Cell Lung Cancer via NLRP3/NF-κB/MAPK Signaling Pathways. Evid Based Complement Alternat Med 2021;2021:6666499. [PMID: 34239588 DOI: 10.1155/2021/6666499] [Reference Citation Analysis]
12 Li X, Zhou X, Liu J, Zhang J, Feng Y, Wang F, He Y, Wan A, Filipczak N, Yalamarty SSK, Jin Y, Torchilin VP. Liposomal Co-delivery of PD-L1 siRNA/Anemoside B4 for Enhanced Combinational Immunotherapeutic Effect. ACS Appl Mater Interfaces 2022. [PMID: 35726706 DOI: 10.1021/acsami.2c01123] [Reference Citation Analysis]
13 Wang D, Li Q, Pan C, Yan L, Sun K, Wang X, Anwaier G, Liao Q, Xie T, Fan J, Huo X, Wang Y, Han J. Yu-Ping-Feng Formula Ameliorates Alveolar-Capillary Barrier Injury Induced by Exhausted-Exercise via Regulation of Cytoskeleton. Front Pharmacol 2022;13:891802. [DOI: 10.3389/fphar.2022.891802] [Reference Citation Analysis]
14 Zheng X, Wang W, Wang G, Liu S. Could Jinfukang alleviate the chemotherapy-related adverse effects in non-small cell lung cancer patients?: A protocol for a double-blind, randomized controlled trial. Medicine (Baltimore) 2021;100:e25002. [PMID: 34260519 DOI: 10.1097/MD.0000000000025002] [Reference Citation Analysis]